Clinical TrialsSearch results
Number of results: 891
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III study of gefitinib versus erlotinib in patients with previously treated lung adeno carcinoma
- Previously treated lung adeno carcinoma
- West Japan Oncology Group
- 2009-06-19
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- squamous cell carcinoma of the lung
- West Japan Oncology Group
- 2009-06-30
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Randomized phase III study of FOLFOX plus bevacizumab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer
- metastatic colorectal cancer
- West Japan Oncology Group
- 2008-09-26
Other
- Allogeneic stem cell transplantation following reduced-intensity conditioning for relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- relapsed/refractory peripheral T-cell non-Hodgkin's lymphomas
- West Japan Hematology Oncology Group/ Hematological Malignancy Therapy Study Group/ Japan Study Group for Cell Therapy and Transplantation
- 2008-11-07
Completed
- Edoxaban Versus Standard of Care and Their Effects on Clinical Outcomes in Patients Having Undergone TAVI - In Atrial Fibrillation
- Atrial Fibrillation
- Watanabe Yusuke
- 2019-02-21
Recruiting
- Efficacy of Delgocitinib for Dermatomyositis
- Dermatomyositis
- Watanabe Tomoya
- 2023-05-16
Completed
- Expiratory randomized phase II trial for optimizing treatment dose and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer(SOAP trial)
- colon cancer
- Watanabe Jun
- 2019-02-07
Recruiting
- SPECTACLE study
- Rectal cancer
- Watanabe Jun
- 2023-07-10